BR reports fiscal Q4 results on August 6 with the stock up 7% on the day before the announcement and the bullish options rotation flagged in this column four days ago now looking validated by price action.
The options signal has softened slightly but remains net bullish. The put/call ratio edged back up to 0.84 after touching its 52-week low of 0.70 late last week, though it remains about 0.6 standard deviations below its 20-day mean of 1.01. That is a meaningful step back from the defensive posture — PCRs above 1.3 — that defined June and early July. The stock has responded: BR closed at $168.41, up 17% over the past month and 6.4% on the week. Peers moved more modestly in the same window, with PAYC up 8.4% and ADP up 2.4%, suggesting BR's move carries a company-specific bid rather than purely sector tailwinds.
The lending market offers no friction for either side of the trade. Borrow availability is extraordinarily loose — over 8,200% — meaning there are roughly 82 shares available to lend for every one currently borrowed. Cost to borrow ticked up 27% over the past week to 0.41%, but in absolute terms that is still negligible. Short interest is a steady 3.5% of the free float, little changed day-over-day, and the ORTEX short score of 35 ranks in the 44th percentile — well inside neutral territory. Bears are present but not pressing.
The fundamental debate is well-defined. Bulls point to recurring revenue up 9.2% year-on-year to $1.07 billion and closed sales jumping 24.3% — signals that demand for Broadridge's investor communications and trade-processing infrastructure remains durable. The CEO bought $1 million of stock in March at around $194, well above where the shares sit today, adding a directional signal from inside the company. Bears focus on the 27.3% drop in event-driven revenue, which has historically been a swing factor in quarterly results, and the guidance for flat adjusted operating margins of 20-21% — a ceiling that limits how much earnings can outpace revenue even if the top line holds. Analyst targets set in May cluster in the $165–$230 range after a wave of post-Q3 cuts; with BR now at $168, the stock has moved through the more cautious targets and is testing the midpoint of the bull-case range.
The August 6 print will therefore test whether the recurring-revenue growth rate has held — or accelerated — enough to offset the drag from event-driven weakness, and whether management raises, narrows, or trims its EPS growth guidance of 9-12%, which is the number the market now needs to recalibrate against a stock that has rallied sharply into the announcement.
See the live data behind this article on ORTEX.
Open BR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
